Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Micic

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|January 25, 2017
Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 TherapiesY Komaki, F Komaki, A Yamada, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2017
Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-α agent (infliximab), in inflammatory bowel diseasesY Komaki, A Yamada, F Komaki, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 1998
Preserved growth hormone (GH) secretion in aged and very old subjects after testing with the combined stimulus GH-releasing hormone plus GH-releasing hexapeptide-6D Micic, V Popovic, M Doknic, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1995
Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic levelV Popovic, S Damjanovic, D Micic, et al.
Clinical Endocrinology|May 1, 1997
Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosaV Popovic, D Micic, M Djurovic, et al.
Clinical Endocrinology|November 1, 1996
The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in manD Micic, V Popovic, A Kendereski, et al.
Clinical Endocrinology|February 1, 1995
Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthoodD Micic, V Popovic, A Kendereski, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1994
Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6V Popovic, S Damjanovic, D Micic, et al.
Hormone Research|December 11, 1999
Growth hormone secretagogues: the clinical futureD Micic, X Casabiell, O Gualillo, et al.
Neuroendocrinology|October 1, 1993
Modulation by glucocorticoids of growth hormone secretion in patients with different pituitary tumorsV Popovic, S Damjanovic, D Micic, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|January 25, 2017
Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 TherapiesY Komaki, F Komaki, A Yamada, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2017
Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-α agent (infliximab), in inflammatory bowel diseasesY Komaki, A Yamada, F Komaki, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 1998
Preserved growth hormone (GH) secretion in aged and very old subjects after testing with the combined stimulus GH-releasing hormone plus GH-releasing hexapeptide-6D Micic, V Popovic, M Doknic, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1995
Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic levelV Popovic, S Damjanovic, D Micic, et al.
Clinical Endocrinology|May 1, 1997
Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosaV Popovic, D Micic, M Djurovic, et al.
Clinical Endocrinology|November 1, 1996
The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in manD Micic, V Popovic, A Kendereski, et al.
Clinical Endocrinology|February 1, 1995
Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthoodD Micic, V Popovic, A Kendereski, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1994
Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6V Popovic, S Damjanovic, D Micic, et al.
Hormone Research|December 11, 1999
Growth hormone secretagogues: the clinical futureD Micic, X Casabiell, O Gualillo, et al.
Neuroendocrinology|October 1, 1993
Modulation by glucocorticoids of growth hormone secretion in patients with different pituitary tumorsV Popovic, S Damjanovic, D Micic, et al.
Pageof 6